Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes

Summary

This study is to evaluate the pharmacokinetics and pharmacodynamics of bardoxolone methyl in patients with chronic kidney disease and type 2 diabetes.

Timeline

Start

2012-04-30

Primary completion

2012-11-30

Completion

2013-10-31

Outcome

Outcome not reported

Stopped: “IDMC recommendation for safety concerns”

Drugs

Indications